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Introduction
The Pharmacy Continence Care Project Stage One was an
Australian Government initiative conducted by the Continence
Advisory Service from 2003 to 2004.  The aims of Stage One of
the project were, firstly, to establish current best practice in the
provision of continence care within community pharmacies in
Australia and internationally.  Continence care has been defined
as “all measures directed toward the prevention, improvement and/or
management of urinary incontinence” 1. In this project, faecal
incontinence was included within the concept of continence
care.  The potential for an enhanced role in continence care to
be played by community pharmacies throughout Australia has
been acknowledged by the Department of Health and Ageing 2 as
an integral component of raising awareness of continence issues
and promoting continence.  It is recognised that pharmacists, as
experts in medication management, have a unique ability to
identify patients who may be at risk of developing incontinence
due to the impact of their medication regimens.  Secondly, the
project aimed to develop a model of best practice based upon
these findings.  Consultant pharmacists appointed by the
Pharmacy Guild of Australia provided pharmaceutical content in
the training manuals. 
There is worldwide recognition of the need to promote
continence by ensuring that a range of health care professionals,
including pharmacists, are educated in continence care 3. The
importance of community pharmacies in identifying, advising,
counselling and referring people who are at risk of, or who have
incontinence, was highlighted by the Hunter Continence
Awareness (HCA) Project  in 2000 4. The HCA Project was an
Australian Federal Government funded project and delivered
continence training to community pharmacy staff and also to
practice nurses in general practice clinics.  Outcomes of the
project resulted in pharmacies having increased continence
knowledge, and improved the confidence of pharmacy staff
when discussing continence issues with customers, including
providing product and medication information.  There are over
5,000 community pharmacies in Australia, and there is a
tremendous potential for these pharmacies to maximise
opportunities to provide continence care. 
Research, including a literature search, field surveys and a fax-
back survey of pharmacists, was conducted.  Focus group
discussions were conducted with consumers to establish preferred
formats of health information.  In addition, a convenience sample
of consumers was surveyed to elicit a rating of their perception of
how knowledgeable pharmacists and pharmacy assistants are in
relation to bladder and bowel control problems.  
Expected outcome from the next stage of this project is to ensure
that people with incontinence are identified and offered
information on treatment services.
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Abstract
Stage One of the Pharmacy Continence Care Project (the project) was undertaken in 2003-2004 by the Continence Advisory Service
of WA Incorporated.  The aim of the project was to establish current best practice in the provision of continence care within
community pharmacies in Australia and internationally, and to develop a model of best practice based upon these findings.  These
materials will be trialed and evaluated in the second stage of the project.  Research, including a literature search, surveys of pharmacy
staff, consumer focus groups and a consumer survey was conducted.  A survey of consumers found that they were generally uncertain
of knowledge levels of pharmacy staff in relation to continence issues.  This uncertainty was demonstrated by consumers indicating that
they would primarily seek continence advice from a doctor or other health care professional rather than a pharmacist.  While a
definitive model was not found, components of a best practice model and opportunities to promote continence were identified.  Stage
one of the project concluded with the development of draft training modules.  In response to input from pharmacy staff, a selection of
supportive material, such as product selection guides was developed to enhance pharmacy staff skills in providing information and
advice on continence care.  The second stage of the project will involve the evaluation and modification of the training materials. 
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Methodology 
Literature search
A literature search was conducted of data on the 
promotion of continence by community pharmacists available in 
journals, books, reports and electronic formats.  Key word
searches were performed using key words such as ‘pharmacy and
(in)continence’, ‘community pharmacy’, ‘continence care’,
‘continence management’, ‘best practice’, ‘pharmaceutical care’
and ‘health promotion and pharmacy’.  It was noted 
that a synonym for ‘community pharmacy’ was ‘retail 
pharmacy’, however this article will only make reference to
community pharmacy. 
Australian and international databases including Australasian
Medical Index, CAB Health, CINAHL, Cochrane Library,
EBSCOHost EJS, Ingenta, International Pharmaceutical
Abstract, Pharmaceutical News Index, Proquest 5000, PubMed,
Science Direct, Medline, Swetswise and Wiley InterScience
were searched in addition to hand searches and review of web
reference sources such as Medscape and web pages such as
Community Pharmacy.  The literature search focused on
research that addressed the key words and were published in
English from 1997 to 2003.  However a few references dated
back to 1985. 
Field visits to community pharmacies 
Field visits were made to 26 community pharmacies, of which 12
were in regional areas and 14 pharmacies were in metropolitan
Perth, WA.  The visits were conducted in addition to the
literature search, to identify current and best practice in relation
to continence care.  Informants from the pharmacies were
interviewed in person or via telephone using a semi-structured
interview which had a mixture of closed and open ended
questions.  Questions chosen for the field visit survey were based
upon the literature search and a previous survey conducted by
the HCA Project 4.
Informants consisted of staff from 24 community pharmacies
consisting of 22 pharmacists and four senior pharmacy assistants
who had been nominated by the pharmacist as the most suitable
staff member to interview.  In two pharmacies, both a pharmacist
and a pharmacy assistant were interviewed.  Information was
sought about their pharmacies and their opinions as to whether or
not best practice in continence care existed, and if not, how it
could be developed.  Due to the small number of pharmacy
assistants that were interviewed, it was not possible to ascertain if
there were any differences between the responses given by
pharmacists and those given by pharmacy assistants. Observational
studies were conducted of the types and location of incontinence
products within pharmacies.  In addition, observation was made of
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health promotion materials particularly with regard to the type of
material and its accessibility to consumers. 
Fax back surveys of pharmacists 
A survey to determine current and best practice in continence
care was sent by facsimile by the Pharmacy Guild of Australia to
a random sample of 600 community pharmacies within Australia
on the Pharmacy Guild membership database.  The survey
consisted of brief demographic information on the state or
territory location and postcode of the responding pharmacy and
nine questions.  These questions are included in Table 1.  Survey
respondents were invited to make additional comments.  The
survey was in a format familiar to pharmacists and was prepared
with the assistance of the Pharmacy Guild of Australia.  One
hundred and seventy-seven responses were received and these
were analysed using the Statistical Package for the Social
Sciences (SPSS®) computer software 5.
Consumer focus groups 
Four focus groups and one individual face to face survey were
conducted, with a sample of 30 people.  Participant recruitment
consisted of a convenience sample of consumer members and
supporters of the WA Branch of the Continence Foundation of
Australia (CFA) consisting of two men and two women, all of
whom were aged over 65 years.  One man who was unable to
attend the focus group was interviewed separately.  A self-selected
group of five women recruited from the Armadale Continence
Self Help Group (ACSHG) attended the second focus group.  All
were aged under 65 years.  The Health Consumer Council
consumers were recruited from a ‘Health Interest Group’ that has
experience in reviewing consumer information.  This group
consisted of 12 consumers made up of two men and 10 women, of
whom four women and the two men were aged over 65 years.
The Mercy Aged Care group was recruited from community aged
care clients attending a day respite centre.  The eight women
participants were aged between 80 and 92 years. 
It is acknowledged that many participants had prior knowledge
of continence terminology and general health issues.  However,
as consumer feedback was sought on presentation aspects of the
leaflets, it was assumed that the qualitative data would not be
unduly influenced by previous knowledge of incontinence issues. 
Following consultation with health consumer experts it was
decided to limit the number of leaflets reviewed to three to five
items per focus group to allow a greater depth of analysis to take
place.  Following recruitment, participants were sent a package
containing a covering letter, the continence information that was
to be reviewed and a ratings sheet on which to record their
impressions of each fact sheet.  The leaflets that were reviewed by
the consumers were Incontinence produced by Amcal 6, Incontinence:
What is it? produced by the CFA 7 and Bladder and urine control
produced by Pharmacy Self-Care® Health Information 8. Two
other leaflets produced by incontinence product manufacturers
were reviewed by the CFA and ACSHG participants.  These were
You’re not alone produced by Kimberly-Clark 9 and either Bladder
weakness 10 or Bladder control produced by Sancella (now SCA
Hygiene Australasia) 11.
There are many features of health information materials that can
be analysed including content, tone, layout, level of information,
graphics and colour choice of a health information brochure 12.
Focus group participants reviewed these aspects, along with font
size, price and readability of the continence information leaflets.
A list of the discussion questions is included in Table 2.
Fax back survey questions sent to a random sample of
community pharmacists 
1. Demographic information: State/Territory and
postcode______________________________________
2. Do you consider continence products (pads etc) to be
a significant business item?               YES ❏ NO ❏
3. Have you or any of your staff had any previous
training in urinary or faecal incontinence? 
YES ❏ NO ❏
4. Please indicate how the training was provided.
_____________________________________________
5. Would you like to participate in incontinence
education and training?                     YES ❏ NO ❏
6. Do you have health information related to
incontinence for customers in your pharmacy? 
YES ❏ NO ❏
7. What format is the information? _________________
8. Where is the continence information held?_________
_____________________________________________
9. What would you identify as current best practice in
continence care in community pharmacy?__________
_____________________________________________
10. What would you consider to be vital components of
current best practice in continence care? ___________
_____________________________________________
11. Any other comments or feedback? ________________
_____________________________________________
Table 1: Pharmacists fax back survey questions.
Focus Group discussion questions
Participants were asked to rate the leaflets in relation to the
following criteria: 
• Appeal of colour scheme
• Size of print
• Ease of reading
• Easy to understand
• Information
• Level of information
• Likelihood of someone picking up the leaflet
• Comments/thoughts on leaflet 
Table 2: Focus group discussion questions.
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Ethical considerations 
Focus groups participants were made aware that the purpose of
the focus group was to discuss their preferred format and
presentation of information in a series of continence information
leaflets.  Participants were informed that discussions would be
kept confidential and identifying data would not be recorded to
ensure privacy.  They were aware that participation was
voluntary and that they were able to withdraw at any point
throughout the discussion.  Ethics approval was not required as
the participants were all able to provide informed consent and
the focus group discussion did not include sensitive personal
issues, but rather consumer’s perceptions of their preferred
format and presentation of continence information leaflets.
The format of the focus group and individual discussion consisted
of semi-structured questions based upon the ratings sheet and
probing questions to elicit extra information and comments.  In
order to collect the qualitative data, transcription of comments
made were recorded verbatim when possible and by annotating
salient comments.  Data was collated by grouping responses to
discussion items allowing common themes to be identified.
Conclusions were drawn from the consumers’ recommendations.
Consumer convenience survey 
A questionnaire was completed by a convenience sample of 29
exhibitors and visitors to the Wanneroo Lions Health Expo.
Consumers were asked to indicate from which health care
professional they had or would seek information on bladder or
bowel control problems and to rate their perception of the
knowledge level of pharmacists and pharmacy assistants in
relation to bladder and bowel control problems.  The response
to these survey questions are discussed in the results below.  Data
was analysed using SPSS ® software 5.
Results
Literature search 
Models of pharmaceutical care consistent with best practice have
been developed for a number of chronic diseases including
asthma and diabetes 13. While pharmacy continence care has
been advocated in Australia and overseas, a definitive model of
best practice was not found to currently exist.  However, a
number of studies have demonstrated opportunities for
community pharmacies to promote continence and have
recommended a number of strategies consistent with best
practice 14, 15. These strategies include dispelling the myth that
incontinence is a normal part of ageing and reassuring the elderly
that much can be done to effectively treat incontinence 16, 17.
Due to their location within the community, pharmacists and
pharmacy assistants are often the first point of contact in the
health care system for many people.  It has been suggested that
pharmacists are the most accessible community health care
provider 18 primarily because pharmacy products and services can
be accessed without an appointment.  Pharmacists are
encouraged to maximise the opportunity to promote continence
as they can “play an integral role in educating the community on
preventative strategies to minimise the onset of incontinence and to
provide practical help and assistance to customers in need” 19.
The pharmacist’s role may include taking the patient’s history,
reviewing their medications, providing advice regarding
beverages and Over the Counter products known to cause
diuresis 20 and supplying incontinence products 14. It is important
that pharmacists conducting Home Medicines Reviews are
aware of the types of incontinence, and have cognisance of
medicines that may cause or exacerbate incontinence and those
used in the pharmacological management of incontinence 15, 21. It
is reported that over 50% of people who are housebound have
continence problems 15.
Pharmacists need to understand the social impact of
incontinence, and to educate patients that incontinence is
manageable 15, 16, 20, 21. Pharmacists also have opportunities to
discuss with clients how common incontinence is, and to
recommend assessment to determine the cause of the problem. 
The availability of high quality consumer health information is a
key component in assisting patients to make informed choices
about their health care 22. Continence can be promoted within
community pharmacies by having leaflets on incontinence and
contact details for local continence services 23. This information
should be displayed in several product departments such as
incontinence products, feminine hygiene sections, home health
care and personal care departments 4.
The literature did not reveal the presence of any tools or guides
that would assist pharmacists to identify patients taking
medicines that could increase the risk of having or developing
incontinence that would then allow the pharmacist to counsel the
patient with regard to their options to better manage or treat
their incontinence.  The literature search also identified a need
for pharmacists to receive training in health promotion 12, 24 and
revealed opportunities to develop a model of best practice in
continence care.  These findings supported a need for a high level
of training to be provided to pharmacists to increase their skills in
these areas and were taken into consideration when developing a
model of best practice for pharmacy continence care.  
Field surveys
Discussions with pharmacists confirmed that a model of best
practice for continence care does not currently exist.
Nevertheless, they were able to identify components that would
be necessary to develop such a model.  These included education
and training of pharmacy staff, particularly in relation to
incontinence product knowledge. 
The currency of health information is important and it was
noted that the majority of pharmacies had information that was
out of date, particularly in relation to contact telephone numbers
for customers to call if they required further information.  
Information in display stands was more accessible to consumers
than storage boxes.  Some pharmacies had incontinence product
information displayed near incontinence products; however this
was not always clearly visible. 
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Observational studies revealed that most pharmacies utilised two
to three metres of shelving for incontinence products.  Some
pharmacies had a few packets of products whereas others had
several metres of shelving that were well stocked with a wide
variety of incontinence products.  It was observed that most
community pharmacies stock incontinence products from two
major incontinence product companies. 
Fax back survey results
Less than half of the pharmacists (46%) indicated that they or
their staff had undergone continence education and training.
Those that had received training indicated that this was provided
by a variety of methods including incontinence product
company representatives (52%), nurse continence advisors
(10%), self-directed professional development (18%), or by a
university (12%).  It is not possible to determine if the training
that was received in university was at an undergraduate or
postgraduate level.  Other responses included courses conducted
by the Pharmacy Guild or Australian Pharmaceutical Industry
and self directed learning from pharmacy profession journals.
One hundred and fifty-seven pharmacists (89%) indicated that
they would like to participate in continence education and
training, with one pharmacist stating “I have little knowledge of
continence and continence products. It would be great to learn more”.
Consumer health information related to incontinence
in pharmacies 
One hundred and forty-four pharmacists (81%) responded that
they had consumer health information related to incontinence in
their pharmacies.  There was a variety in the types of continence
information available in pharmacies.  Of the pharmacies with
continence information 61% had Pharmacy Self-Care ® cards 8,
55% had incontinence product information produced by
incontinence product suppliers, 15% had a computerised health
information source such as a Health Kiosk ® 25, 7% had CFA
continence fact sheets 7, 14% had information produced by
pharmacy marketing groups such as Amcal 6 and 4% had other
information such as information that had been compiled “in-
house”. Some pharmacists had more than one type of
information in their pharmacy.  Table 3 represents the types of
continence information available.
Location of continence information
Observational studies conducted during the field visits revealed
that consumer health information was not always easy to locate.
The fax-back survey was used to establish if this observation
applied to a wider cross-section of pharmacies.  One hundred
and two pharmacies (57%) had continence information stored in
a brochure holder.  Forty-two pharmacies (24%) had
information in a file that was accessible by staff only, 41% had
information displayed near incontinence products, and a further
6% of pharmacies had information stored in other areas.  Some
pharmacists added comments to this section stating that they
had a Health Kiosk ® 25 that was accessible to consumers.   
Identification of current best practice in continence
care in community pharmacy 
Pharmacists were asked to indicate what they considered to be
best practice in continence care within a community pharmacy.
Twenty-eight pharmacists (16%) responded that they were
unsure as to what constituted best practice in continence care
and 31 (17%) did not believe that a best practice model existed.
Significantly 106 (60%) of pharmacists believed that staff with
incontinence product knowledge was a component of best
practice.  In addition, 55 (31%) of pharmacists responded that
having a pharmacy stocked with a wide range of incontinence
products constituted best practice.  More than one response was
given by a number of pharmacists and the results are shown in
Table 4.  
Identification of vital components of best practice in
continence care 
Pharmacists were asked to indicate what they felt were vital
components of best practice in continence care in community
pharmacies.  Component choices included completion of an
accredited Disease State Module (such as have been developed by
the Pharmaceutical Society of Australia for the management of
diabetes 13 and asthma by pharmacists and pharmacy assistants),
continence management algorithm, well trained staff, staff with
incontinence product knowledge, or having a pharmacy stocked
with a wide range of incontinence products.  The results are
shown in Table 5.  Pharmacists were also provided with the
opportunity to identify other vital components of current best
Type of incontinence information N %
Commercial product information 98 55.3
Pharmacy Self Care ® 108 61.1
Health Kiosk ® 27 15.2
Continence Foundation of Australia 
fact sheets 12 6.7
Pharmacy marketing group 
information 24 13.5
Other  6 3.3
Table 3: Types of continence information in pharmacies.
Response N %
Not sure 28 15.8
Don’t think it currently exists 31 17.5
Staff with product knowledge 106 59.8
Wide range of incontinence 
products stocked 55 31.7
Other 4 2.3
Table 4: What would you identify as being current best
practice in pharmacy continence care?
© Continence Foundation of Australia 2005
A u s t r a l i a n  a n d  N e w  Z e a l a n d  C o n t i n e n c e  J o u r n a l
66 Vol. 11, No. 3  • Spring 2005
practice.  They were able to give more than one answer to this
question and additional comments to this question included
“completion of Disease State Module ideally”, “better mark-up on
continence products”, “pharmacy stocked with a reasonable range of
products to suit demand”. In addition, another pharmacist
substituted “reasonable” for “wide” in the statement “pharmacy
stocked with a wide range of incontinence products”.
Results of consumer focus groups
Consumers were consistently critical of the small font size in all
the materials reviewed and reported difficulty reading text that
was contained within shaded areas.  They expressed strong
preferences for materials that were subjectively attractive such as
the Amcal leaflet 6 (now out of production) and the Pharmacy
Self-Care ® card 8, and were critical of unattractive colour
schemes such as the leaflets produced by the CFA 7 and
Kimberly–Clark 9. Consumers had expressed some concern that
the requirement of payment in some pharmacies for Pharmacy
Self-Care ® cards 8 was likely to act as a disincentive for a number
of consumers.  They also stated a preference for non-
commercial sources of information as they believed that those
were more credible.  Preferred choices for information content
were Bladder and urine control produced by Pharmacy Self-Care ®
8 and Urinary incontinence what is it? produced by the CFA 7.
Consumer convenience survey
The questionnaire was completed by 29 people; eight men and
20 women.  The gender of one participant was not stated.  The
age of respondents ranged from 26 to 75 years.  The average age
of the respondents was 55 years for men and 48 years for women.
Consumers were asked to indicate from which health care
professionals they had (or would) seek information on bladder or
bowel control problems.  There was an overwhelming response
that 76% of people would seek this information from a doctor,
and only 1% would seek continence information from a
pharmacist.  This finding supports research which revealed that
there appeared to be a lack of public awareness of the
pharmacist’s skills and knowledge of health issues 26.
The survey rated consumer perceptions of how knowledgeable
pharmacists and pharmacy assistants are in relation to bladder
and bowel control problems.  Table 6 shows that 27.6% of
consumers were unsure as to how knowledgeable pharmacists
were and Table 7 illustrates that 34% of consumers were
unsure of how knowledgeable pharmacy assistants were in
regard to bladder and bowel control problems.  These findings
suggest that there is a need for public awareness activities to
raise awareness of the knowledge and skills of pharmacists and
pharmacy assistants. 
Discussion
Pharmacists have traditionally been associated with a dispensing
role.  Currently within Australia and internationally pharmacists
are expanding their pharmaceutical care role within a range of
health conditions, particularly chronic diseases such as 
diabetes 13. Health promotion is classified as an ‘essential service’
of community pharmacy in the United Kingdom, along with
traditional functions such as dispensing of medicines 27. Within
Australia, the Pharmacy Guild’s Quality Improvement program,
the Quality Care Pharmacy Program includes health promotion
in its range of professional practice activities 28. However, field
visits to community pharmacies found limited evidence of
pharmacy participation in health promotion activities or the
effective use of health promotion materials in relation to
continence care.  The opportunity exists for community
pharmacists to further develop their health care role by
becoming more involved in promoting continence.  
Vital component of best practice N %
Completion of an accredited Disease 
State Module 50 28
Continence management algorithm 35 20
Well trained staff 126 71
Staff with incontinence product 
knowledge 74 78
Pharmacy stocked with a range of 
incontinence products 3 2
Other
Table 5: What would you consider to be vital components
of current best practice in continence care? 
Response N %
Extremely 4 13.8
Moderately 7 24.1
Somewhat 7 24.1
A little 2 6.9
Not sure 8 27.6
Table 6: How knowledgeable do you feel your pharmacist
is about bladder and bowel control problems? 
Response N %
Extremely 2 6.9
Moderately 6 20.7
Somewhat 6 20.7
A little 4 13.8
Not sure 10 34.5
Table 7: How knowledgeable do you feel a  pharmacy
assistant is about bladder and bowel control
problems?
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The response rate of the fax back survey was 30% and it is not
possible to establish if the characteristics of the pharmacists who
completed surveys were the same as those who did not 29. Hence
it is acknowledged that the characteristics of the sample may
have biased the results.
It is acknowledged that community pharmacists have a dual
role in health care and retail business.  The draft Pharmacy
Continence Care program modules reinforced literature that
stressed that incontinence products should be seen as a last
resort 30 and the patient should be aware that there are other
strategies available in the treatment of incontinence 7, 14, 26.
Needing to wear incontinence pads every day has a
significantly negative effect upon sufferers’ quality of life, and
can result in decreased confidence and self-esteem, along with
the inconvenience of having to take spare pads and a change of
clothing when going out 31. Furthermore, the UK Department
of Health 32 advises that the premature offering of incontinence
products may lead to a psychological dependence and may
leave patients disinclined to seek curative treatment.
Comments added to the survey included comments such as it is
“difficult to keep a large range”. A few respondents also
expressed concern that while many customers sought advice on
products in the pharmacy, a number of these then went to a
supermarket to purchase the products at a cheaper price.  One
pharmacist stated “this area of pharmacy has been overlooked and
requires our attention”.
There was recognition of the need for well-trained staff
particularly in relation to incontinence product knowledge.  The
surveys conducted with pharmacists did not seek input as to the
level of training that was required.  However, identification of
completion of an accredited Disease State Module and having a
continence management algorithm were considered to be vital
components of best practice in 28% and 20% of pharmacists
respectively.  Only one pharmacist in the field surveys suggested
that incontinence product representatives should provide
training in continence care.  
Data collected from the literature search and input from
pharmacist and consumer surveys were used in the
development of the Pharmacist Continence Training Module,
Pharmacy Assistants Continence Training Module and the
Pharmacy Continence Care Program Module. The Pharmacy
Continence Care Program Module was based upon the Pharmacy
Asthma Care Program Module 33 and the Pharmacy Diabetes Care
Program Module 34 produced by the Pharmacy Guild of
Australia.  Unlike the pharmaceutical Disease State
Management Training packages available for asthma and
diabetes 13 there were no comprehensive continence care
training packages suitable for pharmacists and pharmacy
assistants, and therefore these had to be developed.  The
Pharmacist Continence Training Module and Pharmacy Assistants
Continence Training Module were developed to contain the
educational content necessary to provide the knowledge, skills
and attitudes necessary for the provision of pharmacy
continence care.  Consultant pharmacists provided information
relating to pharmaceutical content and pharmacy policies and
procedures. The modules were also reviewed by experts
appointed by the Department of Health and Aged Care.   
An interesting finding from the consumer focus groups was that
the older consumers believed that “incontinence” was a term that
would not be understood by younger people.  However, the
younger consumers said that they believed that older people
would not understand what was meant by incontinence.  All
consumers expressed concern that the font size was too small in
all of the publications.  It was felt that continence information
materials should be attractive to increase the chance that they
would be picked up and read by consumers.  Consumers believed
that it was important to ensure that information was titled
appropriately as some leaflets had confusing graphics on them
that “could be for anything”. Consumers had a strong preference
for non-commercial sources of information and preferred text
and diagrams to explain the content.  Despite being considered
to be unattractive in appearance the CFA leaflet Urinary
Incontinence: What is it? 7 along with the more attractive Bladder
and urine control by Pharmacy Self Care ® 8 were the preferred
information sources. 
While the sample size of the consumer survey was small it does
reinforce studies that show that while the pharmacist may not be
viewed as a primary source of health information and advice,
consumers have expressed interest in using pharmacies for this
purpose 24, 35-37. The results of the survey reveal that it may be
necessary to conduct a public awareness campaign in order to
promote the pharmacists’ role in the provision of continence
care.  This was also supported by a number of pharmacists in the
field survey who also expressed a need for a public awareness
campaign if community pharmacies are going to provide
continence care. 
Conclusions
Consumers indicated their preference for non-commercial
health information materials that are attractive and easy to read.
A public awareness campaign to promote the role of community
pharmacies in the provision of continence care and to reassure
consumers of the knowledge level of pharmacy staff will need to
be addressed if the next stages of the Pharmacy Continence Care
Program are to be successfully implemented.
Pharmacists are medicines experts and are therefore well placed
to advise patients with, or at risk of developing, bladder and
bowel control problems caused by or exacerbated by medicines.
Pharmacists have identified having well trained staff with a high
level of incontinence product knowledge as vital components of
a best practice model in pharmacy continence care.  It is
recommended that pharmacy staff members receive training to
ensure that they are able to assist customers with continence
problems, including those seeking information on incontinence
products.  The research data and findings were considered when
developing the draft Pharmacy Continence Care Modules and
supporting materials. 
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